Free pricing in Europe soon to be a thing of the past?
This article was originally published in Scrip
Just three European countries out of 27 surveyed have free pricing policies for pharmaceuticals, says a new report from the Pharmaceutical Pricing and Reimbursement Information (PPRI) project. The report also demonstrates that reference pricing is now the choice pricing system across Europe, a strong indication of the popularity of cost containment measures among health authorities.
You may also be interested in...
Pharmaceutical industry groups say the European Commission’s Pharmaceutical Strategy Roadmap lacks detail on delivering a faster regulatory process and encouraging competitiveness.
The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.
The European Medicines Agency received more requests for scientific advice in 2019 than it did in 2018. Meanwhile, requests for advice in other areas has fallen.